EUVIMEDOpdag EUVIMED
Crossref

The Role and Mechanism of KIAA1429‐Mediated m6A Modification in Pancreatic Adenocarcinoma

Pengbo Li, Yeting Lu, Zhen Zheng, Jiaming Lv, Jing Hu iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70015 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Pengbo Li and 4 co-authors. Institution: School of Medicine, Ningbo University, Ningbo, Zhejiang Province, China. Major MEDLINE topics: Pancreatic Neoplasms, Adenosine, Adenocarcinoma, Methyltransferases. Cited 1 times so far (Crossref); 34 references. Funded by: This study was supported by Ningbo Natural Science Foundation (2022J263)..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This study aimed to study the mechanism by which m6A methyltransferase, KIAA1429, affect pancreatic adenocarcinoma (PAAD) cell malignant behaviors in relation to N6‐methyladenosine (m6A) modification. RT‐qPCR, Western blot, immunohistochemistry (IHC), and m6A RNA immunoprecipitation (Me‐RIP) assays were performed on PAAD tumor and adjacent non‐tumor tissues ( n = 39) to detect KIAA1429, AKT2 mRNA and protein levels, as well as overall tissue RNA m6A methylation levels. Tumor cells were transfected with siRNA targeting KIAA1429 (si‐KIAA1429) or plasmids overexpressing AKT2 (oe‐AKT2). Cell activities were assessed, followed by assessment of autophagic flux using the mRFP‐GFP‐LC3 reporter. In PAAD tissues and cell lines, KIAA1429 was substantially expressed. In PAAD patients, this expression was linked to a considerably lower overall and disease‐specific survival rate. KIAA1429 knockdown inhibited PAAD cell malignant behaviors and promoted autophagy. Mechanistically, KIAA1429 mediated AKT2 m6A modification to enhance AKT2 mRNA stability and upregulate AKT2 expression, partially reversing the mediating effects of KIAA1429 knockdown on PAAD cell malignant behaviors and autophagy. KIAA1429 knockdown also inhibited PAAD tumor growth in vivo. KIAA1429 promotes PAAD cell malignant behaviors while inhibiting autophagy activity by mediating AKT2 m6A modification and enhancing AKT2 expression.

Subjects

MeSH terms (MEDLINE)

Pancreatic NeoplasmsAdenosineAdenocarcinomaMethyltransferasesHumansGene Expression Regulation, NeoplasticAutophagyMiceAnimalsMaleCell Line, TumorFemaleCell ProliferationProto-Oncogene Proteins c-aktMiddle AgedPrognosisMice, NudeMethylationHyaluronoglucosaminidase

Author keywords

AKT2KIAA1429N6‐methyladenosineautophagymRNA stabilitypancreatic adenocarcinoma

Substances

N-methyladenosineAdenosineMethyltransferasesProto-Oncogene Proteins c-aktCEMIP protein, humanHyaluronoglucosaminidase

Authors and institutions

  • School of Medicine, Ningbo University, Ningbo, Zhejiang Province, China.
  • Department of Hepatopancreatobiliary Surgery, Ningbo Medical Center LiHuiLi Hospital, Ningbo, Zhejiang Province, China.
  • Department of Chemoradiotherapy, Ningbo Medical Center LiHuiLi Hospital, Ningbo, Zhejiang Province, China.

ORCID profiles: Jing Hu

Funding

  • This study was supported by Ningbo Natural Science Foundation (2022J263).

Cite

APA

Li, P., Lu, Y., Zheng, Z., Lv, J., & Hu, J. (2025). The Role and Mechanism of KIAA1429‐Mediated m6A Modification in Pancreatic Adenocarcinoma. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70015

Vancouver

Li P, Lu Y, Zheng Z, Lv J, Hu J. The Role and Mechanism of KIAA1429‐Mediated m6A Modification in Pancreatic Adenocarcinoma. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70015

BibTeX
@article{Li2025,
  author = {Li, Pengbo and Lu, Yeting and Zheng, Zhen and Lv, Jiaming and Hu, Jing},
  title = {The Role and Mechanism of KIAA1429‐Mediated m6A Modification in Pancreatic Adenocarcinoma},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70015}
}
Start for free →